GlassScriptPhysician profile
Julio C Molina
NPI 1932225679
$2,533.87
in general payments reported to CMS, 2019-2025
33 companies · $23.56 in 2025
The $23.56 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $250 · 2021: $286 · 2022: $687 · 2023: $490 · 2024: $339 · 2025: $23.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $326.77 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $210.01 | 2019-2024 | Otezla, Repatha |
| Lilly USA, LLC | $205.64 | 2019-2023 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $159.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $136.13 | 2019-2024 | Airsupra |
| Glaxosmithkline, LLC. | $133.58 | 2021-2024 | Shingrix, Fluarix Quadrivalent, Arexvy |
| Nestle Healthcare Nutrition INC. | $125.84 | 2020-2023 | |
| Pfizer INC. | $122.11 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $120.31 | 2019-2023 | Livalo |
| Sanofi-Aventis U.S. LLC | $110.06 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.14 | 2019-2022 | |
| Abbott Laboratories | $84.96 | 2022-2024 | Freestyle Libre 3 |
| Abbvie INC. | $83.92 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.64 | 2020-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $52.29 | 2022-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $51.07 | 2019-2022 | |
| Sanofi Pasteur INC. | $42.40 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $39.78 | 2021 | |
| Inspire Medical Systems, INC. | $38.80 | 2024 | Inspire |
| Amarin Pharma, INC. | $37.08 | 2019 | |
| Exact Sciences Corporation | $33.85 | 2023-2024 | Cologuard Collection Kit |
| Allergan, INC. | $31.09 | 2020 | |
| Aimmune Therapeutics, INC. | $27.97 | 2024 | |
| Aytu Biopharma, INC. | $27.69 | 2019 | |
| Gilead Sciences, INC. | $27.57 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $27.55 | 2020 | |
| Merck Sharp & Dohme LLC | $22.78 | 2019 | |
| Inari Medical, INC. | $17.53 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $16.17 | 2019 | |
| Idorsia Pharmaceuticals US INC | $15.58 | 2023 | Quviviq |
| Arbor Pharmaceuticals, INC. | $13.83 | 2019 | |
| Shield Therapeutics INC | $13.68 | 2022 | |
| Janssen Biotech, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Molina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.